196 related articles for article (PubMed ID: 27842514)
1. Thoracic perfusion of recombinant human endostatin (Endostar) combined with chemotherapeutic agents versus chemotherapeutic agents alone for treating malignant pleural effusions: a systematic evaluation and meta-analysis.
Biaoxue R; Xiguang C; Hua L; Wenlong G; Shuanying Y
BMC Cancer; 2016 Nov; 16(1):888. PubMed ID: 27842514
[TBL] [Abstract][Full Text] [Related]
2. Thoracic perfusion of lobaplatin combined with endostar for treating malignant pleural effusions: A meta-analysis and systematic review.
Wang CQ; Liu FY; Wang W
Medicine (Baltimore); 2022 Oct; 101(40):e30749. PubMed ID: 36221355
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of efficacy and safety for recombinant human adenovirus-p53 in the control of the malignant pleural effusions via thoracic perfusion.
Biaoxue R; Hui P; Wenlong G; Shuanying Y
Sci Rep; 2016 Dec; 6():39355. PubMed ID: 27976709
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of efficacy and safety for Brucea javanica oil emulsion in the control of the malignant pleural effusions via thoracic perfusion.
Fuhong D; Xiang G; Haiying L; Jiangye W; Xueming G; Wenxiao C
BMC Cancer; 2018 Apr; 18(1):411. PubMed ID: 29649989
[TBL] [Abstract][Full Text] [Related]
5. Intraperitoneal Perfusion Therapy of Endostar Combined with Platinum Chemotherapy for Malignant Serous Effusions: A Meta-analysis.
Liang R; Xie HY; Lin Y; Li Q; Yuan CL; Liu ZH; Li YQ
Asian Pac J Cancer Prev; 2015; 16(18):8637-44. PubMed ID: 26745130
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of endostar combined with cisplatin in treatment of non-small cell lung cancer with malignant pleural effusion: A meta-analysis.
Hu Y; Zhou Z; Luo M
Medicine (Baltimore); 2022 Dec; 101(52):e32207. PubMed ID: 36595983
[TBL] [Abstract][Full Text] [Related]
7. Endostar continuous versus intermittent intravenous infusion combined with chemotherapy for advanced NSCLC: a systematic review and meta-analysis including non-randomized studies.
Wang B; Xu L; Li Q; Man S; Jin C; Liu L; Zhan S; Ning Y
BMC Cancer; 2020 Oct; 20(1):1021. PubMed ID: 33087103
[TBL] [Abstract][Full Text] [Related]
8. Intraperitoneal infusion of recombinant human endostatin improves prognosis in gastric cancer ascites.
Zhan Z; Wang X; Yu J; Zheng J; Zeng Y; Sun M; Peng L; Guo Z; Chen B
Future Oncol; 2022 Mar; 18(10):1259-1271. PubMed ID: 35114805
[TBL] [Abstract][Full Text] [Related]
9. Systematic review and meta-analysis of Endostar (rh-endostatin) combined with chemotherapy versus chemotherapy alone for treating advanced non-small cell lung cancer.
Rong B; Yang S; Li W; Zhang W; Ming Z
World J Surg Oncol; 2012 Aug; 10():170. PubMed ID: 22917490
[TBL] [Abstract][Full Text] [Related]
10. Rh-endostatin Concomitant with Chemotherapy Versus Single Agent Chemotherapy for Treating Soft Tissue and Bone Sarcomas: A Systematic Review and Meta-Analysis.
Ma Z; Guo L; Cui X; Liu H; Liu L
J Pharm Pharm Sci; 2018; 21(1):386-397. PubMed ID: 30352660
[TBL] [Abstract][Full Text] [Related]
11. Thoracic perfusion of recombinant mutant human tumor necrosis factor (rmhTNF) can be considered as a good adjunct in the treatment of malignant pleural effusion caused by lung cancer.
Fu T; Lin Y; Zeng Q; Yao W; Han L
BMC Pulm Med; 2020 Jun; 20(1):175. PubMed ID: 32552897
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human endostatin endostar suppresses angiogenesis and lymphangiogenesis of malignant pleural effusion in mice.
Ma X; Yao Y; Yuan D; Liu H; Wang S; Zhou C; Song Y
PLoS One; 2012; 7(12):e53449. PubMed ID: 23285296
[TBL] [Abstract][Full Text] [Related]
13. Effects of intracavitary administration of Endostar combined with cisplatin in malignant pleural effusion and ascites.
Zhao WY; Chen DY; Chen JH; Ji ZN
Cell Biochem Biophys; 2014 Sep; 70(1):623-8. PubMed ID: 24920191
[TBL] [Abstract][Full Text] [Related]
14. The Evaluation of Durative Transfusion of Endostar Combined with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer.
Li X; Gu G; Soliman F; Sanders AJ; Wang X; Liu C
Chemotherapy; 2018; 63(4):214-219. PubMed ID: 30347389
[TBL] [Abstract][Full Text] [Related]
15. Randomized controlled trial of endostar combined with cisplatin/ pemetrexed chemotherapy for elderly patients with advanced malignant pleural effusion of lung adenocarcinoma.
Jie Wang X; Miao K; Luo Y; Li R; Shou T; Wang P; Li X
J BUON; 2018; 23(1):92-97. PubMed ID: 29552766
[TBL] [Abstract][Full Text] [Related]
16. Endostar (rh-endostatin) versus placebo in combination with vinorelbine plus cisplatin chemotherapy regimen in treatment of advanced non-small cell lung cancer: A meta-analysis.
An J; Lv W
Thorac Cancer; 2018 May; 9(5):606-612. PubMed ID: 29575575
[TBL] [Abstract][Full Text] [Related]
17. Endostar combined with chemotherapy versus chemotherapy alone for advanced NSCLCs: a meta-analysis.
Ge W; Cao DD; Wang HM; Jie FF; Zheng YF; Chen Y
Asian Pac J Cancer Prev; 2011; 12(11):2901-7. PubMed ID: 22393961
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Efficacy and Safety for Kanglaite Injection in the Control of the Malignant Pleural Effusions via Thoracic Perfusion: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Zhu G; Wang X; Li J; Zhang Y; Gao R; Zhang X; Xu B; Hu J; Dai M; Chen J
Front Pharmacol; 2021; 12():694129. PubMed ID: 34803667
[No Abstract] [Full Text] [Related]
19. [A multicenter, randomized, double-blind, placebo-controlled safety study to evaluate the clinical effects and quality of life of paclitaxel-carboplatin (PC) alone or combined with endostar for advanced non-small cell lung cancer (NSCLC)].
Han BH; Xiu QY; Wang HM; Shen J; Gu AQ; Luo Y; Bai CX; Guo SL; Liu WC; Zhuang ZX; Zhang Y; Zhao YZ; Jiang LY; Shi CL; Jin B; Zhou JY; Jin XQ
Zhonghua Zhong Liu Za Zhi; 2011 Nov; 33(11):854-9. PubMed ID: 22335953
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of endostar combined with chemotherapy in multi-cycle treatment of patients with advanced non-small cell lung cancer].
Li N; Jin ZL; Liu ZJ; Wang J; Li K
Zhonghua Zhong Liu Za Zhi; 2011 Dec; 33(12):937-42. PubMed ID: 22340106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
